• Stem Cell Transplants Rejuvenate Chinese Bronchiectasis Patients’ Damaged Lungs
  • Rare Disease Groups, Patients Differ on ‘Right to Try’ Bill Before US Congress
  • S. aureus Infection Not Strongly Linked to Decline in Bronchiectasis Patients, Study Reports
  • NORD Fundraiser Sets 7,000-Mile ‘Bike, Run or Walk’ Goal for 7,000 Rare Diseases
  • Aradigm’s Linhaliq NDA for Non-CF Bronchiectasis Fails to Get FDA Approval
  • An Antibiotic-resistant Bacteria Worsens Bronchiectasis, but Does Not Increase Death Rates, Study Shows
  • FDA Advisory Committee Not Convinced of Linhaliq’s Benefits in Bronchiectasis Infections
  • Bronchiectasis May Trigger Autoimmune Inflammatory Disease, Study Suggests
  • Top 10 Bronchiectasis Stories of 2017
  • Artery Condition Increases Risk of Bronchiectasis Patients Having Heart Problem, Study Finds
  • Bronchiectasis Increases Risk of Stroke and Cognitive Dysfunction, Study Suggests
  • FDA Advisory Group Set to Review Linhaliq, Potential Non-CF Bronchiectasis Treatment, on Jan. 11